Short-Term Oral Mifepristone for Central Serous Chorioretinopathy

NCT02354170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Central Serous Chorioretinopathy

Interventions

DRUG: Mifepristone
DRUG: Placebo

Sponsor

Roger Goldberg, M.D., MBA

Collaborators

[object Object]